Appointment of Joint Corporate Broker

RNS Number : 9662H

LXI REIT PLC

29 November 2022

 

29 November 2022

LXI REIT PLC

("LXI REIT" or the "Company")

Appointment of Joint Corporate Broker

The Board of LXi REIT (ticker: LXI), the specialist inflation-protected very long income REIT, announces the appointment of Barclays Bank PLC ("Barclays") as the Company's joint corporate broker alongside existing joint corporate broker Jefferies International Limited, with immediate effect.

Barclays is authorised by the Prudential Regulation Authority ("PRA") and regulated in the United Kingdom by the Financial Conduct Authority and the PRA. Barclays is acting exclusively for the Company and no one else in connection with the corporate broking services or any other matters referred to in this announcement.

FOR FURTHER INFORMATION, PLEASE CONTACT:

LXI REIT Advisors Limited Simon Lee (Partner, Fund Manager) John White (Partner, Fund Manager) Freddie Brooks (CFO)	Via H/Advisors Maitland
Barclays Bronson Albery / Tom Macdonald / Dion Di Miceli	020 7623 2323
J efferies International Tom Yeadon / Ed Matthews / Rishi Bhuchar	020 7029 8000
H/Advisors Maitland (Communications Advisor) James Benjamin / Alistair de Kare-Silver	07747 113 930 / 020 7379 5151 [e-mail]

The Company's LEI is: 2138008YZGXOKAXQVI45

NOTES

LXI REIT plc invests in commercial property assets predominantly in the UK, let, or pre-let, on long (typically 20 to 30 years to expiry or first break), inflation-linked leases to a wide range of strong tenant covenants across a diverse range of robust property sectors.

The Company may invest in fixed-price forward funded developments, provided they are pre-let to an acceptable tenant and full planning permission is in place. The Company will not undertake any direct development activity nor assume direct development risk.

The Company is targeting a dividend of 6.3 pence per ordinary share for the year which commenced on 1 April 2022*.

The Company, a real estate investment trust ( "REIT") incorporated in England and Wales, islisted on the premium listing segment of the Official List of the UK Financial Conduct Authority and was admitted to trading on the main market for listed securities of the London Stock Exchange in February 2017.

The Company is a constituent of the FTSE 250, EPRA/NAREIT, MSCI and STOXX Europe 600 indices.

Further information on the Company is available at www.lxireit.com

*  This is a target and not profit forecast.

 

END

 

 

MSCEADFNAAXAFFA